NCT05805319Recruiting
Dietary Intervention for NSCLC Patients Treated With ICI
Randomized Dietary Intervention to Improve Fiber Intake in Patients With Non-small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Therapy
Source: ClinicalTrials.gov · Last updated 22 Oct 2026
Brief summary (registry, in English)
This is a single-center randomized trial in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibition. Patients will receive standard-of-care immune checkpoint inhibitor (ICI) therapy alone or in combination with a dietary intervention.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- First submitted
- 15 Feb 2023
- Start date
- 27 Apr 2023
- Primary completion date
- 30 Jan 2027
- Lead sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Diseases
- Lung cancer
- NCT number
- NCT05805319
What you commit to
- Study type: Interventional
- Planned participants: 80
- From 27 Apr 2023 to the primary completion date, 30 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe dietary allergies (e.g. shellfish, nuts, seafood)
- Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
Who the study is looking for
- Signed, informed consent
- Age 18 years or older
- Confirmed histological diagnosis of non-small cell lung cancer (NSCLC); Treatment with standard-of-care ICI
- Ability to eat solid foods
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier de l'Universite de Montreal (CHUM) Coordinator of this site? Confirm its status | Montreal | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.